LEADER 03524nam 2200661 450 001 9910461372603321 005 20200520144314.0 010 $a1-62637-336-1 035 $a(CKB)3710000000466065 035 $a(EBL)4352968 035 $a(SSID)ssj0001544234 035 $a(PQKBManifestationID)16135041 035 $a(PQKBTitleCode)TC0001544234 035 $a(PQKBWorkID)14334109 035 $a(PQKB)11328152 035 $a(MiAaPQ)EBC4352968 035 $a(Au-PeEL)EBL4352968 035 $a(CaPaEBR)ebr11150312 035 $a(OCoLC)936881035 035 $a(EXLCZ)993710000000466065 100 $a20160209h20122012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aDriving down the cost of drugs $ebattling big pharma in the statehouse /$fRamo?n Castellblanch 210 1$aBoulder, Colorado ;$aLondon, [England] :$cFirstForumPress,$d2012. 210 4$dİ2012 215 $a1 online resource (186 p.) 300 $aDescription based upon print version of record. 311 $a1-935049-45-3 320 $aIncludes bibliographical references and index. 327 $aTitle page; copyright page; Dedication; Contents; Preface; Acknowledgments; ch1-David, Goliath, and Prescription Drugs; ch2-How Drugs Got So Expensive; Getting Patent Privileges; Making the FDA a Partner and the Rise of the Blockbusters; Fighting Government Oversight and Exploiting the Blockbusters; The Blockbusters' Toll on America; ch3-Vermont Raises the Cry; The Road to S 300; 1999; S 300; Epilogue; ch4-As Goes Maine; Maine Background; Low-cost Drugs for the Elderly; Senate Leadership Commitments to Supporting Price Controls; Leinonen; Northeast Legislators; LD 2599; Industry Response 327 $aPublic Support to the RescueKing-Pingree Negotiations; Maine Rx; PhRMA v. Concannon; Maine Rx Plus; Postscript; ch5-PhRMA Tries Stopping State Action; PhRMA Political Spending in the Early 2000s; Post-Maine Rx State and Local Legislation; PhRMA's Turn to Congress; Industry Building Its Economic Power; Advocates' Continued Fighting after Part D; ch6-So Goes California; California Overview; 1999-2003; 2004: Legislative Leadership Taking the Stage; The Rise of Tension between the Governor and Legislative Leadership; 2005; 2006; Making a Deal; Implementation Delayed 327 $ach7-Politically Organizing for Access to MedicinesHearing Voters' Righteous Indignation; Allying with Powerful Progressive Organizations; Politically Isolating the Pharmaceutical Industry; "Framing" after Righteous Indignation; Inferences beyond Fighting for Medicines; Implications for US Health Policy; Appendix: Useful Websites on Health Care Policy and Politics; Bibliography; Index; About the Book 606 $aPrescription pricing$zCalifornia 606 $aPrescription pricing$zMaine 606 $aPrescription pricing$zVermont 606 $aDrugs$xPrices$zCalifornia 606 $aDrugs$xPrices$zMaine 606 $aDrugs$xPrices$zVermont 608 $aElectronic books. 615 0$aPrescription pricing 615 0$aPrescription pricing 615 0$aPrescription pricing 615 0$aDrugs$xPrices 615 0$aDrugs$xPrices 615 0$aDrugs$xPrices 676 $a368.38/24 700 $aCastellblanch$b Ramo?n$f1948-$0905939 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910461372603321 996 $aDriving down the cost of drugs$92026266 997 $aUNINA